Phase I trial of IRX 4204 in patients with Alzheimer's disease.
Latest Information Update: 18 Sep 2012
At a glance
- Drugs IRX 4204 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Io Therapeutics
- 18 Sep 2012 New trial record